Friday, December 09, 2016 11:37:02 AM
http://www.australian-companies.tsetso.info/company.php?oncosec-medical-australia-pty-ltd-acn-abn-number-615228941
As you noted Jeff...
https://www.aimatmelanoma.org/about-melanoma/melanoma-stats-facts-and-figures/
Not only will the Australian subsidiary speed up enrollment for the registration trial, but it will open OncoSec to the biggest melanoma market in the world post approval. We could be looking at late 2019 if the data is great. Not a long time considering the average time a drug takes from start to market is 10-15 years.
https://www.ncbi.nlm.nih.gov/books/NBK22930/
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM